Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial is evaluating human umbilical cord mesenchymal stem cells for the treatment of sepsis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Sepsis | EARLY_Phase 1 | Status: RECRUITING